Subscribe To
Vectivbio to present at the svb leerink 11th annual global healthcare conference
BASEL, Switzerland, Feb. 08, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical compan...
February 8, 2022, 7:15 am
Vectivbio to present at the svb leerink 11th annual global healthcare conference
BASEL, Switzerland, Feb. 08, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical compan...
February 8, 2022, 7:15 am
Vectivbio to present at the svb leerink 11th annual global healthcare conference
BASEL, Switzerland, Feb. 08, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical compan...
February 8, 2022, 7:15 am
Ultragenyx to host conference call for fourth quarter and full-year 2021 financial results and corporate update
NOVATO, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the developmen...
February 3, 2022, 4:01 pm
Ultragenyx to host conference call for fourth quarter and full-year 2021 financial results and corporate update
NOVATO, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the developmen...
February 3, 2022, 4:01 pm
Ultragenyx to host conference call for fourth quarter and full-year 2021 financial results and corporate update
NOVATO, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the developmen...
February 3, 2022, 4:01 pm
Mindset pharma identifies additional drug candidates from 'family 3' compounds
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) announced that it has synthesized additional promising candidates from its Family 3 of next-generation drug...
February 3, 2022, 8:49 am
Mindset pharma identifies additional drug candidates from 'family 3' compounds
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) announced that it has synthesized additional promising candidates from its Family 3 of next-generation drug...
February 3, 2022, 8:49 am
Mindset pharma identifies additional drug candidates from 'family 3' compounds
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) announced that it has synthesized additional promising candidates from its Family 3 of next-generation drug...
February 3, 2022, 8:49 am
Repare therapeutics to participate in two upcoming virtual investor conferences
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage pr...
February 3, 2022, 7:00 am
Repare therapeutics to participate in two upcoming virtual investor conferences
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage pr...
February 3, 2022, 7:00 am
Repare therapeutics to participate in two upcoming virtual investor conferences
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage pr...
February 3, 2022, 7:00 am
Pharmadrug submits us provisional patent application for cepharanthine to treat prostate cancer
PharmaDrug Inc announced that it has filed a US provisional patent application which details the novel ...
February 1, 2022, 10:03 am
Pharmadrug submits us provisional patent application for cepharanthine to treat prostate cancer
PharmaDrug Inc announced that it has filed a US provisional patent application which details the novel ...
February 1, 2022, 10:03 am
Pharmadrug submits us provisional patent application for cepharanthine to treat prostate cancer
PharmaDrug Inc announced that it has filed a US provisional patent application which details the novel ...
February 1, 2022, 10:03 am
Manganese x energy completes final processing metallurgical phase for battery hill pea, highlighted by novel purification process
Manganese X Energy Corp (TSX-V:MN, OTCQB:MNXXF) has wrapped up the third and final processing metallurgical phase for the upcoming preliminary economi...
February 1, 2022, 9:21 am
Manganese x energy completes final processing metallurgical phase for battery hill pea, highlighted by novel purification process
Manganese X Energy Corp (TSX-V:MN, OTCQB:MNXXF) has wrapped up the third and final processing metallurgical phase for the upcoming preliminary economi...
February 1, 2022, 9:21 am
Manganese x energy completes final processing metallurgical phase for battery hill pea, highlighted by novel purification process
Manganese X Energy Corp (TSX-V:MN, OTCQB:MNXXF) has wrapped up the third and final processing metallurgical phase for the upcoming preliminary economi...
February 1, 2022, 9:21 am
Eos energy: determining fair value based on current backlog and other growth expectations
Eos Energy is developing a novel zinc-based battery system that rivals, and has the potential to disrup...
January 31, 2022, 2:34 pm
Eos energy: determining fair value based on current backlog and other growth expectations
Eos Energy is developing a novel zinc-based battery system that rivals, and has the potential to disrup...
January 31, 2022, 2:34 pm